|
|
 |
|
Viewing report
|
|
|
|
CRO Directory - India
CYGNUS Business Consulting & Research, Dec 2005, Pages: 130
India is fast emerging as a favoured destination for clinical trials by global pharmaceutical and biotech companies that are looking for partnerships or setting up new operations. The major companies involved in Clinical research in India have a wide range of services to offer. Thus, the industry needs to know the companies operating in this field. The directory of ‘Clinical Research Companies in India’ is the answer to it and has been prepared as a ready-reckoner for use by the industry globally – pharma and biotech companies, contract research companies, funding organisations and others. It has been compiled, considering the companies involved in clinical research and support services. As it is an emerging market and also as most of the companies may not be listed on stock exchangers, the list may not be comprehensive.
The directory covers more than 60 companies and each profile includes vital information like description of the company, name of Director/CEO, and contact details. The details have been obtained from published sources like the respective websites of the companies. All the companies are listed in alphabetical order.
Customers who bought this item also bought
Global Clinical Trial Market (2007 - 2010) (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
The Future of eClinical Trial Solutions – Market Forecasts to 2015, Competitive Benchmarking and Case Studies
Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success
|
|
|
|
